Jazz Pharmaceuticals (JAZZ) Change in Taxes (2012 - 2026)

Jazz Pharmaceuticals' Change in Taxes history runs 15 years deep, the most recent figure standing at $37.4 million for Q1 2026.

• In Q1 2026, Change in Taxes rose 187.69% year-over-year to $37.4 million; the TTM figure through Mar 2026 stood at $61.6 million (up 471.23% YoY), while the FY2025 annual figure was $37.2 million, up 352.5% from the prior year.
• Change in Taxes for Q1 2026 stood at $37.4 million, up from -$34.8 million in the prior quarter.
• The five-year high for Change in Taxes was $46.3 million in Q2 2025, with the low at -$35.9 million in Q4 2023.
• The 5-year median for Change in Taxes is $12.7 million (2025), against an average of $4.9 million.
• The sharpest annual moves came in 2023 and 2025: Change in Taxes slumped 2264.41% in 2023, then soared 1358.7% in 2025.
• Jazz Pharmaceuticals' Change in Taxes stood at -$1.5 million in 2022, then plunged by 2264.41% to -$35.9 million in 2023, then climbed by 3.06% to -$34.8 million in 2024, then advanced by 0.16% to -$34.8 million in 2025, then soared by 207.52% to $37.4 million in 2026.
• Business Quant data shows JAZZ's Change in Taxes at $37.4 million in Q1 2026, -$34.8 million in Q4 2025, and $12.7 million in Q3 2025.